We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$116B
AUM Growth
+$12.3B
Cap. Flow
-$2.57B
Cap. Flow %
-2.21%
Top 10 Hldgs %
9.91%
Holding
5,208
New
1,193
Increased
1,491
Reduced
1,580
Closed
489

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$672M
2
MRK icon
Merck
MRK
+$476M
3
META icon
Meta Platforms (Facebook)
META
+$392M
4
MCD icon
McDonald's
MCD
+$372M
5
WFC icon
Wells Fargo
WFC
+$357M

Sector Composition

Rank Sector Weight
1 Technology 15.62%
2 Consumer Discretionary 9.84%
3 Healthcare 7.45%
4 Communication Services 7.19%
5 Financials 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
3051
PUT
Teva Pharmaceuticals
TEVA
$36.9B
$1.49M ﹤0.01%
150,000
-50,000
-25% -$529K
QTEK
3052
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$1.49M ﹤0.01%
+150,498
New +$1.48M
UAA icon
3053
PUT
Under Armour
UAA
$3.04B
$1.48M ﹤0.01%
70,000
+40,100
+134% +$894K
DADA
3054
PUT
DELISTED
Dada Nexus
DADA
$1.48M ﹤0.01%
51,000
+21,000
+70% +$545K
TNDM icon
3055
Tandem Diabetes Care
TNDM
$1.22B
$1.48M ﹤0.01%
15,194
-3,187
-17% -$284K
BAP icon
3056
Credicorp
BAP
$30.9B
$1.48M ﹤0.01%
12,207
-12,246
-50% -$1.6M
STLA icon
3057
PUT
Stellantis
STLA
$16.7B
$1.48M ﹤0.01%
75,000
SNA icon
3058
PUT
Snap-on
SNA
$21.7B
$1.48M ﹤0.01%
+6,600
New +$1.58M
CLLS
3059
Cellectis
CLLS
$286M
$1.47M ﹤0.01%
95,269
-3,431
-3% -$57.7K
HT
3060
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$1.47M ﹤0.01%
137,022
-111,058
-45% -$1.23M
EZPW icon
3061
Ezcorp Inc
EZPW
$1.85B
$1.47M ﹤0.01%
244,291
-132,320
-35% -$836K
ELF icon
3062
e.l.f. Beauty
ELF
$4.96B
$1.47M ﹤0.01%
54,241
-97,344
-64% -$2.79M
FBRX icon
3063
Forte Biosciences
FBRX
$1.57B
$1.47M ﹤0.01%
1,750
+752
+75% +$678K
SIBN icon
3064
SI-BONE Inc
SIBN
$795M
$1.47M ﹤0.01%
46,732
+20,688
+79% +$669K
OGE icon
3065
OGE Energy
OGE
$10.2B
$1.47M ﹤0.01%
43,612
-802,703
-95% -$27.1M
GHL
3066
DELISTED
Greenhill & Co., Inc.
GHL
$1.47M ﹤0.01%
94,303
-95,924
-50% -$1.59M
RAD
3067
PUT
DELISTED
Rite Aid Corporation
RAD
$1.47M ﹤0.01%
+90,000
New +$1.72M
CRZN
3068
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
$1.47M ﹤0.01%
+151,209
New +$1.47M
CYCN icon
3069
Cyclerion Therapeutics
CYCN
$15.2M
$1.46M ﹤0.01%
18,763
+15,339
+448% +$960K
PICC.U
3070
DELISTED
Pivotal Investment Corporation III Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
PICC.U
$1.46M ﹤0.01%
146,441
+35,643
+32% +$357K
GTLS
3071
CALL
DELISTED
Chart Industries
GTLS
$1.46M ﹤0.01%
+10,000
New +$1.47M
BGSX
3072
DELISTED
Build Acquisition Corp.
BGSX
$1.46M ﹤0.01%
+151,209
New +$1.46M
GSEVU
3073
DELISTED
Gores Holdings VII, Inc. Units
GSEVU
$1.46M ﹤0.01%
145,022
-105,986
-42% -$1.07M
MBAC.U
3074
DELISTED
M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
MBAC.U
$1.46M ﹤0.01%
144,503
-105,497
-42% -$1.05M
LEN.B icon
3075
Lennar Class B
LEN.B
$20.7B
$1.45M ﹤0.01%
18,777
+7,998
+74% +$605K

Similar funds

D.E. Shaw & Co's Q2 2021 Portfolio in Review

As of Q2 2021, D.E. Shaw & Co held 5,208 positions worth $116B, up 12% from $104B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

D.E. Shaw & Co's Q2 2021 filing shows 1,193 new, 1,491 increased, 1,580 reduced and 489 closed positions. Its largest new stake was Weatherford International: 4,894,906 shares worth $89.1M. The largest sale was Microsoft, an estimated $672M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q2 2021 buy was Weatherford International: 4,894,906 shares worth $89.1M.
  • D.E. Shaw & Co added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $700M increase.
  • D.E. Shaw & Co's biggest Q2 2021 reduction was Microsoft, cutting an estimated $672M.
  • D.E. Shaw & Co fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $131M.
  • D.E. Shaw & Co's ten largest holdings make up 9.9% of its $116B portfolio in Q2 2021.
  • D.E. Shaw & Co opened 1,193 new positions and closed 489 in Q2 2021.
  • D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $116B.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.